Do 5 alpha reductase inhibitors decrease the risk of recurrent gross hematuria in patients who have had a transurethral prostatectomy?

Auteurs-es

  • Blayne Welk University of Western Ontario, London, ON, Canada
  • Jennifer Reid
  • Michael Ordon
  • Jeffrey Campbell
  • Stephanie Dixon

DOI :

https://doi.org/10.5489/cuaj.7135

Mots-clés :

transurethral prostatectomy; finasteride; dutasteride; benign prostatic hyperplasia; hematuria

Résumé

NA

Téléchargements

Les données relatives au téléchargement ne sont pas encore disponibles.

Publié-e

2021-01-29

Comment citer

Welk, B., Reid, J., Ordon, M., Campbell, J., & Dixon, S. (2021). Do 5 alpha reductase inhibitors decrease the risk of recurrent gross hematuria in patients who have had a transurethral prostatectomy?. Canadian Urological Association Journal, 15(6), 214–6. https://doi.org/10.5489/cuaj.7135

Numéro

Rubrique

Research Letter